• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    1/4/23 12:11:54 PM ET
    $ARQQ
    $CANF
    $CEI
    $CTV
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ARQQ alert in real time by email

     

    On Wednesday, 35 companies reached new 52-week lows.

    Significant Points From Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Rivian Automotive (NASDAQ:RIVN).
    • The smallest company on a market cap basis to set a new 52-week low was SCWorx (NASDAQ:WORX).
    • Vera Therapeutics (NASDAQ:VERA) saw the most pronounced move, as shares traded down 60.93% to hit its new 52-week low.
    • Forward Industries (NASDAQ:FORD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    These stocks set new 52-week lows on Wednesday:

    • Rivian Automotive (NASDAQ:RIVN) shares hit a yearly low of $16.56. The stock was down 1.67% on the session.
    • TIM (NYSE:TIMB) shares reached a new 52-week low of $10.66 on Wednesday morning, moving up 0.47%.
    • GameStop (NYSE:GME) shares set a new yearly low of $16.90 this morning. The stock was down 1.16% on the session.
    • Ginkgo Bioworks Holdings (NYSE:DNA) stock set a new 52-week low of $1.45 on Wednesday, moving down 6.33%.
    • Lithium Americas (NYSE:LAC) shares fell to $17.57 on Wednesday, setting a new 52-week low with a shift of down 0.84%.
    • AMTD Digital (NYSE:HKD) shares reached a new 52-week low of $9.39 on Wednesday morning, moving up 1.63%.
    • Enovix (NASDAQ:ENVX) shares made a new 52-week low of $6.50 on Wednesday. The stock was down 44.64% for the day.
    • Laredo Petroleum (NYSE:LPI) shares fell to $46.70 on Wednesday, setting a new 52-week low with a shift of down 2.33%.
    • Overstock.com (NASDAQ:OSTK) shares hit a yearly low of $17.05. The stock was down 8.42% on the session.
    • Ring Energy (AMEX:REI) stock hit $2.14 on Wednesday morning, setting a new 52-week low for a change of down 1.79%.
    • Ramaco Resources (NASDAQ:METC) stock hit $8.12 on Wednesday morning, setting a new 52-week low for a change of down 1.66%.
    • Arqit Quantum (NASDAQ:ARQQ) shares set a new yearly low of $2.87 this morning. The stock was down 0.83% on the session.
    • Seer (NASDAQ:SEER) shares moved down 18.63% on Wednesday to hit a new 52-week low of $4.66, drifting down 18.63%.
    • Vera Therapeutics (NASDAQ:VERA) shares set a new 52-week low of $6.82. The stock traded down 60.93%.
    • Innovid (NYSE:CTV) stock achieved a new 52-week low on Wednesday morning, hitting $1.05 and moving down 25.0%.
    • D-Wave Quantum (NYSE:QBTS) stock hit a yearly low of $1.33. The stock was down 6.94% for the day.
    • Xeris Biopharma Holdings (NASDAQ:XERS) stock hit a new 52-week low of $1.05. The stock was down 6.25% on the session.
    • First Savings Financial (NASDAQ:FSFG) shares made a new 52-week low of $19.91 on Wednesday. The stock was down 0.2% for the day.
    • SeaStar Medical Holding (NASDAQ:ICU) stock hit a yearly low of $3.53. The stock was up 3.98% for the day.
    • Upexi (NASDAQ:UPXI) shares moved down 3.65% on Wednesday to hit a new 52-week low of $2.53, drifting down 3.65%.
    • Zenvia (NASDAQ:ZENV) shares fell to $1.01 on Wednesday, setting a new 52-week low with a shift of up 1.89%.
    • Camber Energy (AMEX:CEI) shares were down 3.17% for the day, having made a 52-week low of $1.80.
    • Can Fite Biofarma (AMEX:CANF) stock broke to a new 52-week low of $0.55 on Wednesday. Shares of the company traded down 3.13%.
    • Forward Industries (NASDAQ:FORD) stock set a new 52-week low of $1.01 on Wednesday, moving 0.0% (flat).
    • Oriental Culture Holding (NASDAQ:OCG) stock broke to a new 52-week low of $0.45 on Wednesday. Shares of the company traded down 16.3%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Wednesday of $0.78. Shares traded down 8.93%.
    • Novo Integrated Sciences (NASDAQ:NVOS) shares moved down 7.78% on Wednesday to hit a new 52-week low of $0.16, drifting down 7.78%.
    • SCWorx (NASDAQ:WORX) shares reached a new 52-week low of $0.37 on Wednesday morning, moving down 2.62%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ARQQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARQQ
    $CANF
    $CEI
    $CTV

    CompanyDatePrice TargetRatingAnalyst
    Enovix Corporation
    $ENVX
    3/12/2026$6.00Neutral
    BofA Securities
    Vera Therapeutics Inc.
    $VERA
    3/11/2026$88.00Peer Perform → Outperform
    Wolfe Research
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    3/4/2026$14.00Underperform
    BofA Securities
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    More analyst ratings

    $ARQQ
    $CANF
    $CEI
    $CTV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Enovix with a new price target

    BofA Securities initiated coverage of Enovix with a rating of Neutral and set a new price target of $6.00

    3/12/26 8:51:29 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Vera Therapeutics upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Vera Therapeutics from Peer Perform to Outperform and set a new price target of $88.00

    3/11/26 8:30:17 AM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rivian Automotive upgraded by TD Cowen with a new price target

    TD Cowen upgraded Rivian Automotive from Hold to Buy and set a new price target of $20.00

    3/10/26 8:38:01 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $ARQQ
    $CANF
    $CEI
    $CTV
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GameStop Corporation

    SCHEDULE 13G/A - GameStop Corp. (0001326380) (Subject)

    3/26/26 6:39:53 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Ginkgo Bioworks Holdings Inc.

    SCHEDULE 13G/A - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    3/26/26 6:36:47 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Enovix Corporation

    SCHEDULE 13G/A - Enovix Corp (0001828318) (Subject)

    3/26/26 6:24:22 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    $ARQQ
    $CANF
    $CEI
    $CTV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

    RAMAT GAN, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced clinical updates and financial results for the year ended December 31, 2025 and early 2026. Advances in Clinical Programs Pancreatic Cancer Phase 2a study in pancreatic cancer met its primary endpoint of safety in heavily pretreated patients. The study continues to follow patients for overall survival, with data maturing over time; currently more than 30% of patients are alive at last data cut-off. Hepatocellular Carcinoma (HCC)A  pat

    3/26/26 9:27:54 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

    BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Jane Wright-Mitchell, Pharm.D., J.D., as Chief Legal Officer, effective immediately. "Jane has worked with Vera Therapeutics previously as a strategic legal consultant and brings a depth and breadth of experience in supporting companies through regulatory approvals, commercialization, and intellectual property management," said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. "As we near the potential launch of

    3/25/26 7:30:00 AM ET
    $PCVX
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GameStop Reports Fourth Quarter and Fiscal Year 2025 Results

    GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f

    3/24/26 4:02:00 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ARQQ
    $CANF
    $CEI
    $CTV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ferreira Vicente De Moraes

    4 - TIM S.A. (0001826168) (Issuer)

    3/26/26 4:34:31 PM ET
    $TIMB
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by Wright-Mitchell Jane

    4 - Vera Therapeutics, Inc. (0001831828) (Issuer)

    3/25/26 7:08:28 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Wright-Mitchell Jane

    3 - Vera Therapeutics, Inc. (0001831828) (Issuer)

    3/25/26 7:06:41 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARQQ
    $CANF
    $CEI
    $CTV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Flatley Jay T bought $25,281 worth of shares (1,830 units at $13.81) and sold $11,775 worth of shares (580 units at $20.30), increasing direct ownership by 0.78% to 162,070 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    3/5/26 5:10:12 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ARQQ
    $CANF
    $CEI
    $CTV
    Leadership Updates

    Live Leadership Updates

    View All

    Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

    BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Jane Wright-Mitchell, Pharm.D., J.D., as Chief Legal Officer, effective immediately. "Jane has worked with Vera Therapeutics previously as a strategic legal consultant and brings a depth and breadth of experience in supporting companies through regulatory approvals, commercialization, and intellectual property management," said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. "As we near the potential launch of

    3/25/26 7:30:00 AM ET
    $PCVX
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Antimony Emerges as Strategic Growth Play in $4B+ Critical Minerals Market

    Investors eye growth potential as limited supply and rising military/electronics demand drive long-term market expansionNEW YORK, March 9, 2026 /PRNewswire/ -- Market News Updates News Commentary - Antimony is starting to get a lot more attention in the critical minerals industry, especially as governments focus on securing materials needed for defense and advanced technology. The metal is used to strengthen ammunition and military alloys, and it's a key ingredient in flame-retardant materials that protect electronics, vehicles, and aircraft wiring. Antimony is also used in semiconductors, infrared sensors, and certain battery technologies. Because these applications are so important to nati

    3/9/26 9:15:00 AM ET
    $LAC
    $MP
    $PPTA
    Metal Mining
    Basic Materials
    Precious Metals

    Vera Therapeutics Appoints Christopher Hite to Board of Directors

    BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christopher Hite, an accomplished executive with decades of corporate and financial strategy leadership experience in the biopharmaceutical sector, to Vera Therapeutics' Board of Directors. "It is a pleasure to welcome Chris to our Board of Directors at this exciting juncture in Vera Therapeutics' trajectory as we near the potential launch of our first-in-class dual BAFF/APRIL inhibitor for patients with IgA nephropathy," sa

    3/5/26 9:00:22 AM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARQQ
    $CANF
    $CEI
    $CTV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    $ARQQ
    $CANF
    $CEI
    $CTV
    Financials

    Live finance-specific insights

    View All

    GameStop Reports Fourth Quarter and Fiscal Year 2025 Results

    GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f

    3/24/26 4:02:00 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Ramaco Resources Announces First Quarter Class B Stock Dividend Details

    LEXINGTON, Ky., March 16, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ:METC, METCB, ", Ramaco", or the ", Company", )) a leading operator and developer of high-quality, low-cost metallurgical coal in Central Appalachia and developing producer of coal, rare earth elements and critical minerals in Wyoming, today announced the dividend ratio of its previously declared Class B common stock dividend for the first quarter of 2026. As previously announced, the board of directors approved and declared a quarterly Class B common stock dividend of $0.1489 per share of Class B common stock, payable on March 27, 2026 (the "Payment Date"), to shareholders of record on March 13, 2026 (the "Record D

    3/16/26 8:15:00 AM ET
    $METC
    $METCB
    Coal Mining
    Energy

    NACCO INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    CLEVELAND, March 4, 2026 /PRNewswire/ -- Q4 Highlights:Gross profit of $12.0 million increased 42% from 2024 on 5% lower revenueOperating profit of $7.6 million up 95% over 2024 and 12% over Q3 2025 Net loss of $3.8 million compared with net income of $7.6 million in 20242025 net loss includes a $6.0 million after-tax, non-cash pension settlement chargeAdjusted EBITDA of $14.3 million improved 59% over 2024 and 14% over Q3 2025FY Highlights:Net income of $17.6 million, or $2.35/share, versus $33.7 million, or $4.55/share, in 2024Adjusted EBITDA of $48.9 million compared with $59.4 million in 2024 2024 included $13.6 million of business interruption insurance recoveriesNACCO Industries® (NYSE

    3/4/26 4:47:00 PM ET
    $LAC
    $NC
    Metal Mining
    Basic Materials
    Coal Mining
    Energy